News

Symbotic Inc. SYM is scheduled to release its first-quarter fiscal 2025 results on Feb. 5, after market close.

See Zacks Earnings Calendar to stay ahead of market-making news.

The company surpassed the Zacks Consensus Estimate in three of the four trailing quarters and missed once, delivering an average earnings surprise of 190%

Symbotic Inc. Price, Consensus and EPS Surprise

Symbotic Inc. price-consensus-eps-surprise-chart | Symbotic Inc. Quote

Symbiotic’s Q1 Expectations

The Zacks Consensus Estimate for SYM’s revenues is pegged at $489.6 million, suggesting a 32.9% rise from the year-ago quarter’s actual. The top line is expected to have been fueled by progress across its 44 systems in proviso deployment.

Healthy software revenues, driven by the company’s ability to convert its backlog and scale, are likely to have benefited the top line. The partnership with Walmex is expected to have been instrumental in delivering significant ROI for customers in new geographies and expanding its addressable market.

The consensus estimate for loss is pegged at 4 cents per share, whereas it incurred a loss of 2 cents in the year-ago quarter. Cost improvement is likely to have driven the bottom line.

What Our Model Says About SYM

Our model predicts an earnings beat for Symbiotic this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks before they are reported with our Earnings ESP Filter.

SYM has an Earnings ESP of +50.00% and a Zacks Rank of 3 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

Other Stocks to Consider

Here are a few other stocks from the broader Business Services sector, which, according to our model, also have the right combination of elements to beat on earnings this season.

Verisk VRSK: The Zacks Consensus Estimate for the company’s fourth-quarter 2024 revenues is pegged at 734 million, indicating year-over-year growth of 8.4%. The consensus estimate for earnings is pegged at $1.6 per share, implying year-over-year growth of 14.3%. The company beat the consensus estimate in three of the past four quarters and missed once, with an average surprise of 4.2%.

VRSK currently has an Earnings ESP of +3.00% and a Zacks Rank of 3. The company is scheduled to declare its fourth-quarter 2024 results on Feb. 26.

V2X, Inc. VVX: The Zacks Consensus Estimate for the company’s fourth-quarter 2024 revenues is pegged at $1.1 billion, indicating year-over-year growth of 4.7%. For earnings, the consensus mark is pegged at $1.1, suggesting a 7.4% decline from the year-ago quarter’s reported figure. The company beat the consensus estimate in three of the past four quarters and missed once, with an average surprise of 13.4%.

VVX carries an Earnings ESP of +4.2% and a Zacks Rank of 3 at present. The company is scheduled to declare its fourth-quarter 2024 results on Feb. 24.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Verisk Analytics, Inc. (VRSK) : Free Stock Analysis Report

Symbotic Inc. (SYM) : Free Stock Analysis Report

V2X, Inc. (VVX) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.